4Filed Aug 19, 8:00 PM ET

Procter & Gamble (PG) Beauty CEO Freddy Bharucha Receives Award

$PG · PROCTER & GAMBLE Co

Research Summary

AI-generated summary of this SEC filing

Updated

Procter & Gamble (PG) Beauty CEO Freddy Bharucha Receives Award

What Happened
Freddy P. Bharucha, Procter & Gamble’s CEO – Beauty, received equity awards reported on a Form 4. The filing shows an acquisition (award) of 837 shares on 2026-08-19 and a derivative award of 7.281 units on 2026-08-17. Both entries are reported at $0.00 per share on the Form 4 (typical for restricted stock units/awards); the Form 4 does not list a cash purchase price. These are grants/awards (not open-market purchases or sales).

Key Details

  • Transaction dates and types:
    • 2026-08-19: Award/acquisition of 837 shares @ $0.00 (reported as A).
    • 2026-08-17: Award/acquisition of 7.281 derivative units @ $0.00 (reported as A; derivative).
  • Report filing date: 2026-08-20 (Form accession 0000080424-26-000139).
  • Shares owned after the transactions: not specified in the provided summary data.
  • Footnotes (from the filing):
    • F1: Award made under the issuer’s 2025 Stock and Incentive Compensation Plan.
    • F2: Total includes dividend equivalents settled in the form of RSUs that will be paid in common stock.
    • F3: Total includes shares acquired via the issuer’s dividend reinvestment plan.
    • F4: Some dividend-equivalent RSUs were previously awarded under the issuer’s retirement program and represent contingent rights to receive stock.
    • F5: These units will convert to shares on retirement unless delivery is deferred or contributed to a deferred compensation account.
  • No indication in the provided data that this was a sale, a 10b5-1 plan trade, or a late filing.

Context
These transactions are equity awards/RSU-type grants. The small 7.281 amount is a derivative/dividend-equivalent RSU rather than a stock purchase or option exercise; such units typically convert to shares under the plan rules or upon retirement. Awards reported at $0.00 on Form 4 reflect the nature of the grant reporting, not the market value of the underlying shares. Awards are routine executive compensation and do not necessarily indicate a personal buy/sell decision.